Latest Insider Transactions at Quanterix Corp (QTRX)
This section provides a real-time view of insider transactions for Quanterix Corp (QTRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Quanterix Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Quanterix Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2022
|
Michael A Doyle CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.07%
|
$455
$13.3 P/Share
|
|
Nov 03
2022
|
Michael A Doyle CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.07%
|
$385
$11.07 P/Share
|
|
Oct 12
2022
|
David R Walt |
SELL
Bona fide gift
|
Direct |
1,000
-0.07%
|
-
|
|
Oct 03
2022
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
1,431
+0.56%
|
$14,310
$10.48 P/Share
|
|
Oct 03
2022
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
1,379
+4.75%
|
$13,790
$10.48 P/Share
|
|
Oct 03
2022
|
Karen Flynn |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+6.87%
|
$10,660
$10.48 P/Share
|
|
Oct 03
2022
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
1,326
+1.08%
|
$13,260
$10.48 P/Share
|
|
Sep 30
2022
|
Michael A Doyle CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.07%
|
$385
$11.02 P/Share
|
|
Aug 15
2022
|
Michael A Doyle CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
15,000
+23.58%
|
$150,000
$10.16 P/Share
|
|
Aug 12
2022
|
Masoud Toloue President & CEO |
BUY
Open market or private purchase
|
Direct |
105,000
+36.1%
|
$1,050,000
$10.43 P/Share
|
|
Aug 12
2022
|
Michael A Doyle CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
15,000
+30.86%
|
$150,000
$10.43 P/Share
|
|
Aug 11
2022
|
Sarah E. Hlavinka |
BUY
Open market or private purchase
|
Direct |
10,160
+17.7%
|
$91,440
$9.92 P/Share
|
|
Aug 10
2022
|
David R Walt |
BUY
Open market or private purchase
|
Direct |
150,000
+9.49%
|
$1,200,000
$8.62 P/Share
|
|
Aug 10
2022
|
Martin D Madaus |
BUY
Open market or private purchase
|
Indirect |
89,667
+26.04%
|
$717,336
$8.43 P/Share
|
|
Aug 10
2022
|
Paul M Meister |
BUY
Open market or private purchase
|
Direct |
234,304
+31.81%
|
$1,874,432
$8.56 P/Share
|
|
Aug 01
2022
|
Masoud Toloue President & CEO |
SELL
Open market or private sale
|
Direct |
446
-0.55%
|
$6,690
$15.61 P/Share
|
|
Aug 01
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
401
-1.05%
|
$6,015
$15.61 P/Share
|
|
Aug 01
2022
|
Michael A Doyle CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
37
-0.2%
|
$555
$15.61 P/Share
|
|
Jul 13
2022
|
Michael A Doyle CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
434
-2.27%
|
$7,812
$18.16 P/Share
|
|
Jul 05
2022
|
Masoud Toloue President & CEO |
SELL
Open market or private sale
|
Direct |
432
-0.53%
|
$6,912
$16.57 P/Share
|
|
Jul 05
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
960
-0.11%
|
$15,360
$16.57 P/Share
|
|
Jul 05
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
387
-1.01%
|
$6,192
$16.57 P/Share
|
|
Jul 01
2022
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
893
+4.65%
|
$14,288
$16.79 P/Share
|
|
Jul 01
2022
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
819
+4.84%
|
$13,104
$16.79 P/Share
|
|
Jul 01
2022
|
Karen Flynn |
BUY
Grant, award, or other acquisition
|
Direct |
164
+1.21%
|
$2,624
$16.79 P/Share
|
|
Jul 01
2022
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
893
+0.74%
|
$14,288
$16.79 P/Share
|
|
Jun 13
2022
|
Masoud Toloue President & CEO |
SELL
Open market or private sale
|
Direct |
5,564
-6.38%
|
$83,460
$15.27 P/Share
|
|
Jun 06
2022
|
Karen Flynn |
BUY
Grant, award, or other acquisition
|
Direct |
13,227
+50.0%
|
-
|
|
Jun 02
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
378
-0.97%
|
$6,426
$17.47 P/Share
|
|
Jun 02
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
712
-0.08%
|
$12,104
$17.47 P/Share
|
|
May 02
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
429
-0.55%
|
$9,438
$22.49 P/Share
|
|
May 02
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
649
-0.04%
|
$14,278
$22.49 P/Share
|
|
Apr 25
2022
|
Masoud Toloue President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,562
+29.53%
|
-
|
|
Apr 25
2022
|
E Kevin Hrusovsky Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
25,594
+2.73%
|
-
|
|
Apr 07
2022
|
John J Fry General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,037
+18.71%
|
-
|
|
Apr 07
2022
|
Michael A Doyle CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
13,555
+41.53%
|
-
|
|
Apr 01
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
261
-0.7%
|
$7,569
$29.79 P/Share
|
|
Apr 01
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
524
-1.7%
|
$15,196
$29.79 P/Share
|
|
Apr 01
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
171
-0.76%
|
$4,959
$29.79 P/Share
|
|
Apr 01
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
868
-0.1%
|
$25,172
$29.79 P/Share
|
|
Apr 01
2022
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
492
+2.75%
|
$14,760
$30.47 P/Share
|
|
Apr 01
2022
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
451
+2.86%
|
$13,530
$30.47 P/Share
|
|
Apr 01
2022
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.41%
|
$14,760
$30.47 P/Share
|
|
Mar 23
2022
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
3,266
-5.63%
|
$97,980
$30.0 P/Share
|
|
Mar 01
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
267
-0.36%
|
$8,277
$31.68 P/Share
|
|
Mar 01
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
371
-0.6%
|
$11,501
$31.68 P/Share
|
|
Mar 01
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
589
-0.03%
|
$18,259
$31.68 P/Share
|
|
Mar 01
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
166
-0.37%
|
$5,146
$31.68 P/Share
|
|
Feb 09
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
1,364
-0.15%
|
$46,376
$34.97 P/Share
|
|
Feb 09
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
318
-0.84%
|
$10,812
$34.97 P/Share
|